Effect of aspirin treatment duration on clinical outcomes in acute coronary syndrome patients with early aspirin discontinuation and received P2Y12 inhibitor monotherapy

Recent clinical trials showed that short aspirin duration (1 or 3 months) in dual antiplatelet therapy (DAPT) followed by P2Y12 inhibitor monotherapy reduced the risk of bleeding and did not increase the ischemic risk compared to 12-month DAPT in acute coronary syndrome (ACS) patients undergoing per...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Ming-Yun, Chen, Po-Wei, Feng, Wen-Han, Su, Chun-Hung, Huang, Sheng-Wei, Cheng, Chung-Wei, Yeh, Hung-I, Chen, Ching-Pei, Huang, Wei-Chun, Fang, Ching-Chang, Lin, Hui-Wen, Lin, Sheng-Hsiang, Hsieh, I-Chang, Li, Yi-Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115803/
https://www.ncbi.nlm.nih.gov/pubmed/33979377
http://dx.doi.org/10.1371/journal.pone.0251109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115803/
https://www.ncbi.nlm.nih.gov/pubmed/33979377
http://dx.doi.org/10.1371/journal.pone.0251109

Ejemplares similares